betaxolol and atenolol

betaxolol has been researched along with atenolol in 54 studies

Research

Studies (54)

Timeframe	Studies, this research(%)	All Research%
pre-1990	15 (27.78)	18.7374
1990's	17 (31.48)	18.2507
2000's	10 (18.52)	29.6817
2010's	8 (14.81)	24.3611
2020's	4 (7.41)	2.80

Authors

Authors	Studies
Ball, JB; Iakovidis, D; Jackman, G; Louis, WJ; Nero, TL; Tung, L	1
Baldwin, JJ; Christy, ME; Denny, GH; Freedman, MB; Gross, DM; Habecker, CN; Lyle, PA; Ponticello, GS; Sweet, CS; Varga, SL	1
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H	1
Baldwin, JJ; Denny, GH; Freedman, MB; Gross, DM; Hirschmann, R; Ponticello, GS; Sweet, CS	1
Iakovidis, D; Jackman, GP; Louis, SN; Louis, WJ; Nero, TL	1
Topliss, JG; Yoshida, F	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Abraham, MH; Acree, WE; Ibrahim, A	1
Lombardo, F; Obach, RS; Waters, NJ	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Campillo, NE; Guerra, A; Páez, JA	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Dargie, HJ; Findlay, IN; McLenachan, JM; Wilson, JT	1
Beckwith, LJ; Benn, JJ; Brown, PM; Farebrother, M; Sönksen, PH	1
Abe, Y; Aki, Y; Fujisawa, Y; He, H; Horiuchi, K; Iwao, H; Kiyomoto, H; Nishiyama, A; Shoji, T; Tamaki, T	1
Irvine, NA; Lipworth, BJ; McDevitt, DG	2
Ashton, P; Lee, VH; Podder, SK	1
Burris, JF	1
Bessho, H; Kitada, Y; Narimatsu, A; Suzuki, J; Tobe, A	1
Sambol, NC; Sheiner, LB	1
Bessho, H; Kitada, Y; Narimatsu, A; Satoh, N; Suzuki, J; Tobe, A	1
Goldie, RG; Henry, PJ	1
Abe, Y; Narimatsu, A; Tobe, A	1
Belz, GG; Palm, D; Wellstein, A	1
Buckley, SK; Geiger, G; Giesa, FR; Grimes, D; Heaslip, RJ; Henry, DE; Lee, DK; Rimele, TJ	1
Bal, IS; Chrysant, C; Chrysant, SG; Hitchcock, A; Trus, J	1
Bauer, JH; Reams, GP	1
Andersen, RL; Haack, DG; Kunka, RL; Wong, YY	1
Birmingham, AT; Patrick, JM; Wharrad, HJ; Wilson, CG	1
Riddell, JG; Shanks, RG	1
Akiyama, K; Hashimoto, K; Mitsuhashi, H	1
Amiel, A; Boutaud, P; Ciber, MA; Demange, J; Herpin, D	1
Barker, AH; Burris, JF; Citron, DC; Hogan, LB; McDonald, RH; Mroczek, WJ	1
Blaive, B; Lemoigne, F; Lewest, G; Nahon, F	1
Engel, G	1
Kompella, UB; Lee, VH; Lee, YH	1
Burger, AJ; Kamalesh, M; Kumar, S; Nesto, R	1
Clark, AF; Gracy, RW; Ke, TL	1
Chidlow, G; Melena, J; Osborne, NN	1
Clark, JI; Martin, RW; Vaezy, S; Zderic, V	1
Antunes, E; Arantes, EC; Baracat, JS; De Nucci, G; Teixeira, CE	1
Chantasart, D; Hao, J; Li, SK	1
Arjomandi-Behzad, L; Rezazadeh, M; Yamini, Y	1
Behpour, M; Ghoreishi, SM; Khoobi, A; Masoum, S	1
Del Amo, EM; Fayyaz, A; Gardner, I; Heikkinen, EM; Jamei, M; Ranta, VP; Reinisalo, M; Ricci, GD; Toropainen, E; Urtti, A; Vellonen, KS	1
Del Amo, EM; Fayyaz, A; Gardner, I; Jamei, M; Puranen, J; Ranta, VP; Ruponen, M; Toropainen, E; Urtti, A; Valtari, A; Vellonen, KS	1
Del Amo, EM; Fayyaz, A; Gardner, I; Heikkinen, EM; Jamei, M; Puranen, J; Ranta, VP; Reinisalo, M; Ricci, GD; Ruponen, M; Toropainen, E; Urtti, A; Valtari, A; Vellonen, KS	1
Alam, SD; Ali, I; Aljuwayid, AM; Jain, AK; Raja, R; Shirsath, V; Sillanpää, M; Yusuf, K	1

Reviews

3 review(s) available for betaxolol and atenolol

Article	Year
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists. Journal of medicinal chemistry, 1988, Volume: 31, Issue:11 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship	1988
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Chiral separation of β-blockers by supercritical fluid chromatography using Chiralpak-IG and Chiralpak IBN-5 columns. Chirality, 2022, Volume: 34, Issue:6 Topics: Adrenergic beta-Antagonists; Atenolol; Betaxolol; Chromatography, Supercritical Fluid; Propranolol; Stereoisomerism	2022

Trials

11 trial(s) available for betaxolol and atenolol

Article	Year
Twenty-four-hour beta-blockade in stable angina pectoris: a study of atenolol and betaxolol. Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:2 Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Betaxolol; Blood Pressure; Double-Blind Method; Half-Life; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Ventricular Function, Left	1992
The effects of time and dose on the relative beta 1- and beta 2-adrenoceptor antagonism of betaxolol and atenolol. British journal of clinical pharmacology, 1991, Volume: 31, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Betaxolol; Dose-Response Relationship, Drug; Electrocardiography; Exercise; Female; Heart Rate; Humans; Isoproterenol; Male; Time Factors	1991
Population dose versus response of betaxolol and atenolol: a comparison of potency and variability. Clinical pharmacology and therapeutics, 1991, Volume: 49, Issue:1 Topics: Adolescent; Adult; Aged; Atenolol; Betaxolol; Blood Pressure; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Placebos	1991
Treatment of severe hypertension with atenolol and betaxolol with once-daily regimens. Hemodynamic aspects. Chest, 1989, Volume: 96, Issue:3 Topics: Adrenergic beta-Antagonists; Atenolol; Betaxolol; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Furosemide; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Minoxidil; Propanolamines; Random Allocation	1989
Steady-state fluctuation and variability of betaxolol and atenolol plasma levels. Therapeutic drug monitoring, 1989, Volume: 11, Issue:5 Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Betaxolol; Biological Availability; Humans; Individuality; Male	1989
The effect of a week's beta-adrenoceptor antagonism on daytime heart-rates, subjective responses to exercise, and physical activity in normal subjects. British journal of clinical pharmacology, 1985, Volume: 19, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Betaxolol; Clinical Trials as Topic; Double-Blind Method; Heart Rate; Humans; Male; Middle Aged; Physical Exertion; Propanolamines; Propranolol; Time Factors	1985
Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses. Clinical pharmacology and therapeutics, 1985, Volume: 38, Issue:5 Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Betaxolol; Blood Pressure; Heart Rate; Humans; Isoproterenol; Male; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Vascular Resistance	1985
[Comparative pharmacoclinical study of 2 beta-blockers: atenolol and betaxolol in slight-to-moderate arterial hypertension]. Annales de cardiologie et d'angeiologie, 1987, Volume: 36, Issue:9 Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Betaxolol; Female; Humans; Hypertension; Male; Propanolamines; Random Allocation	1987
Comparison of the antihypertensive effects of betaxolol to atenolol. The American journal of cardiology, 1988, Apr-01, Volume: 61, Issue:10 Topics: Adrenergic beta-Antagonists; Atenolol; Betaxolol; Blood Pressure; Bradycardia; Clinical Trials as Topic; Double-Blind Method; Fatigue; Headache; Humans; Hypertension; Propanolamines; Random Allocation; Time Factors	1988
[Long-term beta adrenergic antagonists in spastic bronchopathies]. Allergie et immunologie, 1988, Volume: 20, Issue:4 Topics: Adrenergic beta-Antagonists; Asthma; Atenolol; Betaxolol; Bronchitis; Drug Evaluation; Drug Tolerance; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Propanolamines; Time Factors	1988
Effect of beta adrenergic receptor blockade on cardiac autonomic tone in patients with chronic stable angina. Pacing and clinical electrophysiology : PACE, 1996, Volume: 19, Issue:4 Pt 1 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Autonomic Nervous System; Betaxolol; Electrocardiography, Ambulatory; Exercise Test; Female; Fourier Analysis; Heart; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Signal Processing, Computer-Assisted	1996

Other Studies

40 other study(ies) available for betaxolol and atenolol

Article	Year
Computer-aided mapping of the beta-adrenoceptor. 1. Explanation for effect of para substitution on blocking activity at the beta-1-adrenoceptor. Journal of medicinal chemistry, 1992, Dec-11, Volume: 35, Issue:25 Topics: Adrenergic beta-Antagonists; Computer Simulation; Propanolamines; Stereoisomerism; Structure-Activity Relationship	1992
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted amino)-2-hydroxypropoxy]phenyl]imidazole class. 2. Journal of medicinal chemistry, 1986, Volume: 29, Issue:6 Topics: Adrenergic beta-Antagonists; Animals; Female; Guinea Pigs; Heart Rate; Hydrogen Bonding; Imidazoles; In Vitro Techniques; Receptors, Adrenergic, beta; Solubility; Structure-Activity Relationship	1986
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted-amino)-2-hydroxypropoxy]phenyl]imidazole class. Journal of medicinal chemistry, 1983, Volume: 26, Issue:7 Topics: Adrenergic alpha-Agonists; Animals; Female; Guinea Pigs; Heart; Imidazoles; Indicators and Reagents; Isoproterenol; Magnetic Resonance Spectroscopy; Receptors, Adrenergic; Receptors, Adrenergic, beta; Structure-Activity Relationship	1983
LK 204-545, a highly selective beta1-adrenoceptor antagonist at human beta-adrenoceptors. European journal of pharmacology, 1999, Feb-19, Volume: 367, Issue:2-3 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; CHO Cells; Cricetinae; Cyclopropanes; Female; Humans; Imidazoles; In Vitro Techniques; Ligands; Phenoxypropanolamines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Trachea; Urea	1999
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs. European journal of medicinal chemistry, 2008, Volume: 43, Issue:3 Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR. European journal of medicinal chemistry, 2011, Volume: 46, Issue:1 Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics	2011
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Glucose turnover in type I diabetic subjects during exercise. Effect of selective and nonselective beta-blockade and insulin withdrawal. Diabetes care, 1992, Volume: 15, Issue:11 Topics: Adult; Atenolol; Betaxolol; Blood Glucose; Diabetes Mellitus, Type 1; Exercise; Glucose; Glycated Hemoglobin; Humans; Insulin; Kinetics; Male; Physical Exertion; Propranolol; Tritium	1992
Regional hemodynamic effects of betaxolol, a new selective beta 1-blocker, and atenolol in conscious spontaneously hypertensive rats. Japanese journal of pharmacology, 1992, Volume: 60, Issue:3 Topics: Animals; Atenolol; Betaxolol; Blood Pressure; Cardiac Output; Heart Rate; Hypertension; Male; Microspheres; Rats; Rats, Inbred SHR; Regional Blood Flow; Vascular Resistance	1992
The effects of chronic dosing on the beta 1 and beta 2-adrenoceptor antagonism of betaxolol and atenolol. European journal of clinical pharmacology, 1991, Volume: 40, Issue:5 Topics: Adult; Atenolol; Betaxolol; Blood Pressure; Exercise; Heart Rate; Humans; Isoproterenol; Receptors, Adrenergic, beta	1991
Formulation influence on conjunctival penetration of four beta blockers in the pigmented rabbit: a comparison with corneal penetration. Pharmaceutical research, 1991, Volume: 8, Issue:9 Topics: Animals; Atenolol; Benzalkonium Compounds; Betaxolol; Chromatography, High Pressure Liquid; Conjunctiva; Cornea; Edetic Acid; Hydrogen-Ion Concentration; Levobunolol; Male; Ophthalmic Solutions; Rabbits; Timolol	1991
Dose comparability of atenolol and betaxolol. Clinical pharmacology and therapeutics, 1991, Volume: 50, Issue:3 Topics: Atenolol; Betaxolol; Blood Pressure; Half-Life; Humans; Therapeutic Equivalency	1991
[Antihypertensive effect of betaxolol, a cardioselective beta-adrenoceptor antagonist, in renal hypertensive dogs]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1990, Volume: 95, Issue:6 Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Female; Heart Rate; Hypertension, Renal; Male; Propranolol	1990
Effects of betaxolol on cardiohemodynamics and coronary circulation in anesthetized dogs: comparison with atenolol and propranolol. Japanese journal of pharmacology, 1990, Volume: 54, Issue:2 Topics: Animals; Atenolol; Betaxolol; Blood Pressure; Cardiac Output; Coronary Circulation; Dogs; Female; Heart; Heart Rate; Hemodynamics; Male; Propranolol	1990
Beta 1-adrenoceptors mediate smooth muscle relaxation in mouse isolated trachea. British journal of pharmacology, 1990, Volume: 99, Issue:1 Topics: Animals; Atenolol; Betaxolol; Cocaine; Desoxycorticosterone; In Vitro Techniques; Isoproterenol; Male; Mice; Mice, Inbred CBA; Muscle Relaxation; Muscle, Smooth; Norepinephrine; Propanolamines; Receptors, Adrenergic, beta; Trachea	1990
Betaxolol, a cardioselective beta-adrenoceptor antagonist, attenuates ischemic myocardial acidosis in dogs. Japanese journal of pharmacology, 1990, Volume: 53, Issue:2 Topics: Acidosis; Animals; Atenolol; Betaxolol; Blood Pressure; Coronary Circulation; Coronary Disease; Dogs; Electrocardiography; Female; Heart Rate; Hydrogen-Ion Concentration; Male; Propranolol	1990
Affinity and selectivity of beta-adrenoceptor antagonists in vitro. Journal of cardiovascular pharmacology, 1986, Volume: 8 Suppl 11 Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Binding, Competitive; Bisoprolol; Propanolamines; Propranolol; Rats; Salivary Glands; Tritium	1986
Comparison of the beta-adrenoceptor affinity and selectivity of cetamolol, atenolol, betaxolol, and ICI-118,551. Journal of cardiovascular pharmacology, 1988, Volume: 12, Issue:2 Topics: Acetamides; Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Dogs; Dose-Response Relationship, Drug; Female; Guinea Pigs; In Vitro Techniques; Male; Norepinephrine; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta	1988
The effect of triple drug therapy on renal function in patients with essential hypertension. Journal of clinical pharmacology, 1989, Volume: 29, Issue:9 Topics: Adrenergic beta-Antagonists; Aged; Aldosterone; Antihypertensive Agents; Atenolol; Betaxolol; Blood Pressure; Body Weight; Drug Therapy, Combination; Electrolytes; Heart Rate; Humans; Hypertension; Kidney Function Tests; Male; Metolazone; Middle Aged; Minoxidil; Renin	1989
Effects of betaxolol, a new beta 1 selective blocker, on canine ventricular arrhythmias. Japanese journal of pharmacology, 1987, Volume: 43, Issue:2 Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Betaxolol; Blood Pressure; Dogs; Electrocardiography; Epinephrine; Female; Male; Ouabain; Propanolamines	1987
Subclasses of beta-adrenoceptors--a quantitative estimation of beta 1- and beta 2- adrenoceptors in guinea pig and human lung. Postgraduate medical journal, 1981, Volume: 57 Suppl 1 Topics: Aged; Animals; Atenolol; Betaxolol; Cell Membrane; Guinea Pigs; Humans; Iodocyanopindolol; Lung; Metoprolol; Middle Aged; Models, Biological; Pindolol; Practolol; Propanolamines; Receptors, Adrenergic; Receptors, Adrenergic, beta	1981
Systemic absorption pathways of topically applied beta adrenergic antagonists in the pigmented rabbit. Experimental eye research, 1993, Volume: 57, Issue:3 Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Biological Availability; Conjunctiva; Eye; Levobunolol; Male; Nasal Mucosa; Nasolacrimal Duct; Rabbits; Time Factors; Timolol	1993
Age-related permeability changes in rabbit corneas. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1999, Volume: 15, Issue:6 Topics: Aging; Animals; Atenolol; Betaxolol; Chromatography, High Pressure Liquid; Cornea; Dexamethasone; Diffusion; Eye Injuries; Female; Fluoresceins; Gonadotropin-Releasing Hormone; In Vitro Techniques; Permeability; Rabbits; Solubility; Suprofen	1999
Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists. British journal of pharmacology, 2000, Volume: 130, Issue:4 Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Batrachotoxins; Betaxolol; Binding, Competitive; Carteolol; Cerebral Cortex; Dose-Response Relationship, Drug; Kinetics; Levobunolol; Membranes; Propranolol; Rats; Rats, Wistar; Saxitoxin; Sodium; Sodium Channels; Sodium Radioisotopes; Synaptosomes; Timolol; Tritium	2000
Ocular drug delivery using 20-kHz ultrasound. Ultrasound in medicine & biology, 2002, Volume: 28, Issue:6 Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Carteolol; Cornea; Drug Delivery Systems; Epithelium; Models, Animal; Permeability; Rabbits; Timolol; Ultrasonics	2002
Effects of beta-adrenoceptor antagonists in the neural nitric oxide release induced by electrical field stimulation and sodium channel activators in the rabbit corpus cavernosum. European journal of pharmacology, 2005, Sep-05, Volume: 519, Issue:1-2 Topics: Aconitine; Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Binding Sites; Electric Stimulation; In Vitro Techniques; Insect Proteins; Male; Metoprolol; Muscle Relaxation; Neurotoxins; Nitric Oxide; Penis; Propanolamines; Propranolol; Rabbits; Saxitoxin; Scorpion Venoms; Sodium Channel Agonists; Tetrodotoxin; Veratridine	2005
Evaluation of skin permeation of β-blockers for topical drug delivery. Pharmaceutical research, 2013, Volume: 30, Issue:3 Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Atenolol; Betaxolol; Epidermis; Humans; Middle Aged; Propranolol; Skin; Skin Absorption; Timolol; Young Adult	2013
Pulsed electromembrane method for simultaneous extraction of drugs with different properties. Analytical biochemistry, 2013, Jul-15, Volume: 438, Issue:2 Topics: Adrenergic beta-Antagonists; Atenolol; Betaxolol; Chemical Fractionation; Electrochemical Techniques; Humans; Molecular Structure; Reproducibility of Results; Sensitivity and Specificity	2013
Multivariate curve resolution-alternating least squares assisted by voltammetry for simultaneous determination of betaxolol and atenolol using carbon nanotube paste electrode. Bioelectrochemistry (Amsterdam, Netherlands), 2013, Volume: 94 Topics: Atenolol; Betaxolol; Biosensing Techniques; Dielectric Spectroscopy; Electrochemistry; Electrodes; Humans; Hydrogen-Ion Concentration; Least-Squares Analysis; Limit of Detection; Nanotubes, Carbon	2013
Ocular Intracameral Pharmacokinetics for a Cocktail of Timolol, Betaxolol, and Atenolol in Rabbits. Molecular pharmaceutics, 2020, 02-03, Volume: 17, Issue:2 Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Aqueous Humor; Atenolol; Betaxolol; Chromatography, Liquid; Drug Combinations; Half-Life; Injections, Intraocular; Intraocular Pressure; Male; Metabolic Clearance Rate; Rabbits; Tandem Mass Spectrometry; Timolol; Tissue Distribution	2020
Topical ocular pharmacokinetics and bioavailability for a cocktail of atenolol, timolol and betaxolol in rabbits. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2020, Dec-01, Volume: 155 Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Biological Availability; Chromatography, Liquid; Ophthalmic Solutions; Rabbits; Tandem Mass Spectrometry; Timolol	2020
Ocular pharmacokinetics of atenolol, timolol and betaxolol cocktail: Tissue exposures in the rabbit eye. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2021, Volume: 166 Topics: Administration, Ophthalmic; Animals; Aqueous Humor; Atenolol; Betaxolol; Biological Availability; Drug Combinations; Ophthalmic Solutions; Outcome Assessment, Health Care; Rabbits; Solubility; Tears; Timolol; Tissue Distribution	2021